vs
Side-by-side financial comparison of Incyte (INCY) and LANDSTAR SYSTEM INC (LSTR). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.1× LANDSTAR SYSTEM INC). Incyte runs the higher net margin — 23.8% vs 3.4%, a 20.5% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (19.8% vs 1.6%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs -2.2%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Landstar System, Inc. is an American transportation services company specializing in logistics and, more specifically, third-party logistics. Landstar utilizes an extensive network of over 8,800 independent owner-operators, referred to internally as business capacity owners (BCOs), over 1,000 independent freight agents, and over 70,000 vetted carriers. Landstar provides services principally throughout the United States and to a lesser extent in Canada and between the U.S. and Canada, Mexico, ...
INCY vs LSTR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.2B |
| Net Profit | $303.3M | $39.4M |
| Gross Margin | — | 9.6% |
| Operating Margin | 23.7% | 4.5% |
| Net Margin | 23.8% | 3.4% |
| Revenue YoY | 19.8% | 1.6% |
| Net Profit YoY | 91.7% | 32.3% |
| EPS (diluted) | $1.47 | $1.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.2B | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.0B | $1.2B |
| Q1 26 | $303.3M | $39.4M | ||
| Q4 25 | $299.3M | $23.9M | ||
| Q3 25 | $424.2M | $19.4M | ||
| Q2 25 | $405.0M | $41.9M | ||
| Q1 25 | $158.2M | $29.8M | ||
| Q4 24 | $201.2M | $46.2M | ||
| Q3 24 | $106.5M | $50.0M | ||
| Q2 24 | $-444.6M | $52.6M |
| Q1 26 | — | 9.6% | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | — | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | — | ||
| Q2 24 | 92.7% | — |
| Q1 26 | 23.7% | 4.5% | ||
| Q4 25 | 22.3% | 2.5% | ||
| Q3 25 | 32.5% | 2.2% | ||
| Q2 25 | 43.6% | 4.6% | ||
| Q1 25 | 19.5% | 3.4% | ||
| Q4 24 | 25.6% | 4.8% | ||
| Q3 24 | 12.8% | 5.2% | ||
| Q2 24 | -45.8% | 5.6% |
| Q1 26 | 23.8% | 3.4% | ||
| Q4 25 | 19.9% | 2.0% | ||
| Q3 25 | 31.1% | 1.6% | ||
| Q2 25 | 33.3% | 3.5% | ||
| Q1 25 | 15.0% | 2.6% | ||
| Q4 24 | 17.1% | 3.8% | ||
| Q3 24 | 9.4% | 4.1% | ||
| Q2 24 | -42.6% | 4.3% |
| Q1 26 | $1.47 | $1.16 | ||
| Q4 25 | $1.46 | $0.70 | ||
| Q3 25 | $2.11 | $0.56 | ||
| Q2 25 | $2.04 | $1.20 | ||
| Q1 25 | $0.80 | $0.85 | ||
| Q4 24 | $0.90 | $1.30 | ||
| Q3 24 | $0.54 | $1.41 | ||
| Q2 24 | $-2.04 | $1.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $411.0M |
| Total DebtLower is stronger | — | $26.1M |
| Stockholders' EquityBook value | $5.6B | $799.0M |
| Total Assets | $7.3B | $1.6B |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $411.0M | ||
| Q4 25 | $3.1B | $452.2M | ||
| Q3 25 | $2.5B | $434.4M | ||
| Q2 25 | $2.0B | $426.2M | ||
| Q1 25 | $1.9B | $473.4M | ||
| Q4 24 | $1.7B | $566.6M | ||
| Q3 24 | $1.3B | $531.3M | ||
| Q2 24 | $987.3M | $504.0M |
| Q1 26 | — | $26.1M | ||
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 |
| Q1 26 | $5.6B | $799.0M | ||
| Q4 25 | $5.2B | $795.7M | ||
| Q3 25 | $4.7B | $888.7M | ||
| Q2 25 | $4.2B | $921.8M | ||
| Q1 25 | $3.7B | $930.8M | ||
| Q4 24 | $3.4B | $972.4M | ||
| Q3 24 | $3.2B | $1.0B | ||
| Q2 24 | $3.0B | $1.0B |
| Q1 26 | $7.3B | $1.6B | ||
| Q4 25 | $7.0B | $1.6B | ||
| Q3 25 | $6.3B | $1.7B | ||
| Q2 25 | $5.8B | $1.7B | ||
| Q1 25 | $5.7B | $1.7B | ||
| Q4 24 | $5.4B | $1.8B | ||
| Q3 24 | $5.0B | $1.8B | ||
| Q2 24 | $4.7B | $1.8B |
| Q1 26 | — | 0.03× | ||
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
